Psychedelic Stocks Archives - Page 30 of 61

ThursdayApr 20, 2023 11:13 am

Psychedelic-Assisted Therapy May Soon Gain Accreditation Standards

As the prevalence of mental health conditions increases, so does interest in new treatments for these disorders. One particular area of interest is psychedelic-assisted psychotherapy, which involves the supervised administration of psychedelic drugs, such as psilocybin and ketamine, in conjunction with therapy. Psychedelics have been used for centuries by Indigenous communities for their spiritual and religious ceremonies. These substances are known to alter an individual’s mood and perception as well as their cognitive processes. This means these treatments possess the potential to make cognitive behavioral therapy and other talk therapies more effective. Given these effects, patients are bound to be…

WednesdayApr 19, 2023 3:32 pm

The Case for Decriminalizing Psychedelics Nationally

Interest in psychedelics has increased these last few years, mainly as a result of numerous studies that have found that the substances possess a range of medical benefits. The decriminalization of psychedelics is also said to benefit society at large, with improvements being seen in public health and wellness. This is backed by findings from a survey done in Portugal, which found a drop in drug-related adverse outcomes and no reported rise in drug use. Portugal decriminalized the private and public use, possession and acquisition of all drugs in 2000 in an effort to reorient policy towards a health-led approach.…

TuesdayApr 18, 2023 1:38 pm

Study Finds DMT May Be Useful in Treatment of MDD

DMT (N,N-Dimethyltryptamine) is a potent hallucinogenic drug that occurs in many plants and animals. It is commonly used as a psychedelic drug and prepared by different cultures for ritual ceremonies as an entheogen. This drug can be ingested, inhaled or injected. A recently concluded trial has found that DMT may be useful in the treatment of major depressive disorder (MDD). Major depressive disorder refers to a mood disorder that causes an individual to lose interest in activities that usually elicit joy; the mood also results in persistent sadness. The study was conducted by Small Pharma, a company focused on the…

MondayApr 17, 2023 1:49 pm

New Book Explores Religious Interest in Psychedelics

The psychedelic renaissance is here, with numerous studies showing that psychedelics, including LSD, psilocybin, MDMA and ketamine. may be useful in the treatment of mental health conditions, such as addiction, depression, anxiety and psychological distress. Veteran religion journalist Don Lattin recently wrote a book describing how these drugs may prompt a spiritual awakening. In his latest book, “God on Psychedelics,” Lattin looks into how various religious groups are encouraging experiences of human unity and interconnectedness through the substances. He starts by discussing entheogens, which refer to psychoactive drugs that are consumed for spiritual or religious purposes. Lattin talks about priests,…

FridayApr 14, 2023 12:06 pm

Research Finds That People Used Psychedelics in Bronze Age

A new study has found that ancestors in the Bronze Age frequently indulged in psychedelics. The Bronze Age is a historic period that lasted between 3300 BC–1200 BC. This period got its name from the use of bronze, marking the maiden time people started working with metal. The study found that humans living on Menorca, one of the Balearic Islands in the Mediterranean Sea that belong to Spain, regularly consumed mind-altering substances extracted from plants. Researchers confirmed this by analyzing hair samples retrieved from a burial site thought to be from the Bronze Age. Their discovery represents the first confirmed…

ThursdayApr 13, 2023 3:16 pm

Legal Psychedelics Industry May Be Valued at Half a Trillion by 2030

During the virtually held Sequire investment conference last week, delegates heard various pitches from start-up companies that specialize in legalized psychedelic treatments and drugs designed for the treatment of a range of mental disorders. As spending on mental health increases, investors seek to inject funds into the multibillion-dollar market for legalized psychedelics such as ketamine, MDMA and hallucinogenic mushrooms. In the future, some hope that compounds derived from LSD will also be legalized. Numinus Wellness CEO and president Payton Nyquvest expects that the mental health services market will be valued at $538 billion by the year 2030. The majority of…

WednesdayApr 12, 2023 3:49 pm

Why Psychedelic Trips Cause Geometric Visual Effects

For decades, psychedelics have maintained a niche but dedicated following of users because of their potent hallucinogenic effects. Some people have gone through such intense psychedelic experiences that they have experienced Now that researchers worldwide are studying psychedelics such as psilocybin and MDMA for their therapeutic potential, scientists, clinicians and even psychedelic enthusiasts are even more interested in how hallucinogenics affect the human mind. One of the most prevalent questions so far is why psychedelic trips often cause users to see geometric visual hallucinations. These kinds of hallucinations involve seeing complex geometric patterns and shapes. They often involve Euclidean symmetry,…

TuesdayApr 11, 2023 2:28 pm

Israeli Firm Starts Testing Psychedelic Nasal Spray as PTSD Treatment

The next few decades will likely see psychedelic treatments go from relative obscurity to playing center stage in the psychiatric space. After decades of prohibition, psychedelics are now emerging as a potential alternative to traditional mental health therapies amid a surge in psychedelic research. Numerous studies have revealed that hallucinogenic drugs can deliver significant mental health benefits when paired with talk therapy. Psychedelics may finally allow people to gain long-term relief from conditions such as post-traumatic stress disorder and depression, which often fail to respond to conventional treatments. Although a lot of psychedelic research has occurred in Western countries such…

MondayApr 10, 2023 1:45 pm

Connecticut Legislators Pass Bill Decriminalizing Psilocybin

A Connecticut legislative committee recently approved a measure to decriminalize possessing small amounts of magic mushrooms. The legislation reclassifies the possession of up to half an ounce of psilocybin mushrooms as a civil infraction with a $150 fine. Repeat offenders would be charged higher fines ranging from $200 to $500, and those who were convicted three times for psilocybin possession would be directed to a drug-education program. Joint Committee on Judiciary cochair Representative Steven Stafstrom said that although the measure does not legalize psilocybin outright or allow for therapeutic and recreational use, the legislation acknowledges the fact that psilocybin possession…

ThursdayApr 06, 2023 3:45 pm

Study Shows US Special Forces Veterans Experience Decreased PTSD, Alcohol Misuse After Psychedelic Treatment

A recent study has found that U.S. Special Forces veterans who underwent psychedelic treatment had lower levels of PTSD and alcohol misuse. Military veterans are much more likely to experience mental health conditions such as PTSD and depression, but existing treatments aren’t always effective. Psychedelics are poised to play a major role in the evolution of the psychiatric industry over the next decade as researchers work to develop safer and more effective treatments. Research into psychedelic drugs including psilocybin, mescaline and MDMA has found that they can alleviate the symptoms of several mental health conditions with minimal side effects. Hallucinogenics’…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

Category: Psychedelic Stocks